These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
435 related items for PubMed ID: 16647575
1. Kinetics of plasma-cell chimerism after allogeneic stem cell transplantation by highly sensitive real-time PCR based on sequence polymorphism and its value to quantify minimal residual disease in patients with multiple myeloma. Kröger N, Zagrivnaja M, Schwartz S, Badbaran A, Zabelina T, Lioznov M, Ayuk F, Zander A, Fehse B. Exp Hematol; 2006 May; 34(5):688-94. PubMed ID: 16647575 [Abstract] [Full Text] [Related]
2. Quantitative analysis of chimerism after allogeneic stem cell transplantation by real-time polymerase chain reaction with single nucleotide polymorphisms, standard tandem repeats, and Y-chromosome-specific sequences. Koldehoff M, Steckel NK, Hlinka M, Beelen DW, Elmaagacli AH. Am J Hematol; 2006 Oct; 81(10):735-46. PubMed ID: 16838323 [Abstract] [Full Text] [Related]
3. [Application of sequential and quantitative monitoring of chimerism in allogeneic hematopoietic stem cell transplantation]. Tang XW, Wu DP, Zhu ZL, Wang W, Sun AN, Qiu HY, Fu ZZ, Chang WR, Ruan CG. Zhonghua Xue Ye Xue Za Zhi; 2004 Feb; 25(2):78-81. PubMed ID: 14990044 [Abstract] [Full Text] [Related]
11. Levels of minimal residual disease detected by quantitative molecular monitoring herald relapse in patients with multiple myeloma. Fenk R, Ak M, Kobbe G, Steidl U, Arnold C, Korthals M, Hünerlitürkoglu A, Rohr UP, Kliszewski S, Bernhardt A, Haas R, Kronenwett R. Haematologica; 2004 May; 89(5):557-66. PubMed ID: 15136219 [Abstract] [Full Text] [Related]
12. Polymerase chain reaction-based detection of minimal residual disease in multiple myeloma patients receiving allogeneic stem cell transplantation. Martinelli G, Terragna C, Zamagni E, Ronconi S, Tosi P, Lemoli R, Bandini G, Testoni N, Amabile M, Ottaviani E, Buonamici S, Soverini S, Montefusco V, de Vivo A, Bonifazi F, Tura S, Cavo M. Haematologica; 2000 Sep; 85(9):930-4. PubMed ID: 10980631 [Abstract] [Full Text] [Related]
13. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning. Petersen SL. Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527 [Abstract] [Full Text] [Related]
16. Evaluation of mixed hematopoietic chimerism in pediatric patients with leukemia after allogeneic stem cell transplantation by quantitative PCR analysis of variable number of tandem repeat and testis determination gene. Wang LJ, Chou P, Gonzalez-Ryan L, Huang W, Haut PR, Kletzel M. Bone Marrow Transplant; 2002 Jan; 29(1):51-6. PubMed ID: 11840144 [Abstract] [Full Text] [Related]
17. Mesenchymal stem cells are present in peripheral blood and can engraft after allogeneic hematopoietic stem cell transplantation. Villaron EM, Almeida J, López-Holgado N, Alcoceba M, Sánchez-Abarca LI, Sanchez-Guijo FM, Alberca M, Pérez-Simon JA, San Miguel JF, Del Cañizo MC. Haematologica; 2004 Dec; 89(12):1421-7. PubMed ID: 15590390 [Abstract] [Full Text] [Related]
19. Prognostic role of minimal residual disease in multiple myeloma patients after non-myeloablative allogeneic transplantation. Galimberti S, Benedetti E, Morabito F, Papineschi F, Callea V, Fazzi R, Stelitano C, Andreazzoli F, Guerrini F, Ciabatti E, Martino M, Nobile F, Iacopino P, Petrini M. Leuk Res; 2005 Aug; 29(8):961-6. PubMed ID: 15978948 [Abstract] [Full Text] [Related]
20. Quantitative assessment of hematopoietic chimerism by quantitative real-time polymerase chain reaction of sequence polymorphism systems after hematopoietic stem cell transplantation. Qin XY, Li GX, Qin YZ, Wang Y, Wang FR, Liu DH, Xu LP, Chen H, Han W, Wang JZ, Zhang XH, Li JL, Li LD, Liu KY, Huang XJ. Chin Med J (Engl); 2011 Aug; 124(15):2301-8. PubMed ID: 22029079 [Abstract] [Full Text] [Related] Page: [Next] [New Search]